Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2017-10-31 19:00:27
Reporting Period:
Accepted Time:
2017-10-31 19:00:27
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1437786 Immune Design Corp. IMDZ () 4
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1216504 W Lewis Coleman C/o Immune Design Corp.
1616 Eastlake Ave. E., Suite 310
Seattle WA 98102
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-10-27 65,000 $4.07 125,000 No 4 P Indirect By Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 3,000 Indirect By Wife's IRA
  1. The price reported on Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $4.00 to $4.10 on October 27, 2017. The reporting person will provide upon request to the SEC, the issuer or security holder of Issuer, full information regarding the number of shares purchased at each separate price.
  2. On September 20, 2016, the reporting person filed a Form 4 which inadvertently reported that the acquisition of 50,000 shares of the Issuer's Common Stock was held directly by the reporting person. Subsequently, on December 22, 2016, the reporting person disposed of 10,000 shares. This Form 4 corrects the reporting person's holdings to reflect that the remaining 40,000 shares are held indirectly by the reporting person's trust.